Demirel Naciye YILDIRIM, Ercan BIÇAKCI, Tuğrul ELVERDİ, Mustafa Nuri YENEREL, Düz Reyhan KÜÇÜKKAYA, Öner DOĞAN, Meliha NALÇACI

Dekompanse kalp yetmezliği bulguları ile başvuran bir primer efüzyon lenfoma olgusu

Primer efüzyon lenfoması (PEL), vücut boşluklarının seröz zarlarda solid kitle ilişkisiz olarak gelişen ve lenfomatöz efüzyon ile kendini gösteren, nadir bir Hodgkin dışı lenfoma alt grubudur. Primer efüzyon lenfoması, özellikle HIV (Human immunodeficiency virus) ve HHV-8 (Human herpesvirus-8) ile infekte bağışıklığı baskılanmış kişilerde tanımlanmış olsa da, son yıllarda HIV veya HHV-8 infekte olmayan olgular da bildirilmektedir. Bu yazıda, 76 yaşında dekompanse kalp yetmezliği tablosu ile başvuran, HIV ve HHV-8 negatif PEL tanısı konularak R-COP protokolü ile başarıyla tedavi edilen bir olgu sunuldu.

Anahtar Kelimeler:

Erkek, Yaşlı, Lenfoma, primer efüzyon, Ekokardiyografi, Kalp yetmezliği

A case applied with decompensated heart failure findings diagnosed as primary effusion lymphoma

Primary Effusion Lymphoma (PEL) is an infrequent subtype of Non-Hodgkin`s Lymphoma which is characterized by lymphomatous effusions in body cavities, not-associated with mass lesions. Generally PEL is reported in immunocompromised patients infected with human immunodeficiency virus (HIV) and Human Herpes Virus-8 (HHV-8). Recently HIV and HHV-8 negative cases were also reported. Here, we report a 76 year-old man with HIV and HHV-8 negative PEL successfully treated with R-COP chemotherapy protocol.

Keywords:

Male, Aged, Lymphoma, Primary Effusion, Echocardiography, Heart Failure,

PDF

___

1) Jenkins C, Sorour Y, Blake E, Elliot R, Al-Sabah AI, Green J. Human-immunodeficiency-virus-negative, human-herpes-virus-8-negative abdominal cavity primary effusion lymphoma. Clin Oncol (R Coll Radiol) 2005;17:636-8.
2) Matsumoto Y, Nomura K, Ueda K, Satoh K, Yasuda N, Taki T, et al. Human herpesvirus 8-negative malignant effusion lymphoma: a distinct clinical entity and successful treatment with rituximab. Leuk Lymphoma 2005;46:415-9.
3) Pérez CL, Rudoy S. Anti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virusnegative patient. Clin Diagn Lab Immunol 2001; 8:993-6.
4) Kamihira S, Jiann C, Uemura A, Tsuruda K, Hasegawa H, Sugahara K, et al. A subtype of aggressive B-cell lymphoma with an unusual presentation of effusion without masses. Leuk Lymphoma 2006; 47:1991-3.
5) Lechapt-Zalcman E, Challine D, Delfau-Larue MH, Haioun C, Desvaux D, Gaulard P. Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus-seronegative man. Arch Pathol Lab Med 2001; 125:1246-8.
6) Shimazaki M, Fujita M, Tsukamoto K, Matsuki T, Iwata M, Takahashi H, et al. An unusual case of primary effusion lymphoma in a HIV-negative patient not pathogenetically associated with HHV8. Eur J Haematol 2003;71:62-7.
7) Shirokov D, Kadyrova E, Anokhina M, Kondratyeva T, Gourtsevich V, Tupitsyn N. A case of HHV-8- associated HIV-negative primary effusion lymphoma in Moscow. J Med Virol 2007;79:270-7.
8) Das DK. Serous effusions in malignant lymphomas: a review.Diagn Cytopathol 2006;34:335-47.
9) Youngster I, Vaisben E, Cohen H, Nassar F. An unusual cause of pleural effusion. Age Ageing 2006; 35:94-6.
10) Lim ST, Rubin N, Said J, Levine AM. Primary effusion lymphoma: successful treatment with highly active antiretroviral therapy and rituximab. Ann Hematol 2005;84:551-2.